BRAF and Miyoshi myopathy: To date, based on single-cell sequencing, Amit et al. identified resistance pathways and therapeutic targets in relapsed MM [12], and Lohr et al. revealed metabolic reprogramming as a resistance mechanism in BRAF-mutated MM [13].